Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors

INTRODUCTION: The objective of this study was to describe the correlation between the commercially available assay for anti-S1/RBD IgG and protective serum neutralizing antibodies (nAb) against SARS-CoV-2 in an adult population after SARS-CoV-2 vaccination, and determine if clinical variables impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Slotkin, Rebecca, Kyriakides, Tassos C., Kundu, Anupam, Stack, Gary, Sutton, Richard E., Gupta, Shaili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464955/
https://www.ncbi.nlm.nih.gov/pubmed/37643190
http://dx.doi.org/10.1371/journal.pone.0289713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464955/
https://www.ncbi.nlm.nih.gov/pubmed/37643190
http://dx.doi.org/10.1371/journal.pone.0289713

Ejemplares similares